Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a member of the tumor necrosis factor superfamily, and considered a promising tumor therapeutic agent since it selectively targets tumor cells without producing cytotoxicity in healthy cells. Here, TNF is linked to neoplasm.